Literature DB >> 32622399

Investing in surgery: a value proposition for African leaders.

Desmond T Jumbam1, Ché L Reddy1, Emmanuel Makasa2, Adeline A Boatin3, Khama Rogo4, Kathryn M Chu5, Benetus Nangombe6, Olufemi T Oladapo7, John G Meara1, Salome Maswime8.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32622399      PMCID: PMC7332255          DOI: 10.1016/S0140-6736(20)30482-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
Globally, poor access to high-quality surgical, obstetric, and anaesthesia care remains a main contributor to global disease burden accounting for about a third of deaths worldwide. The need for strengthening surgical care systems is especially urgent in sub-Saharan Africa, where access is strikingly limited, leading to the highest mortality and morbidity from surgically preventable and treatable conditions in the world.2, 3 Approximately 93% of the population of sub-Saharan Africa lacks access to safe, affordable, and timely surgical care, compared with less than 10% in high-income countries. Despite the immense and growing need for surgical services in sub-Saharan Africa, investments by African public sector leaders to improve surgical systems on the subcontinent have been inadequate. The current COVID-19 pandemic has disrupted health care globally, with an estimation by the CovidSurg Collaborative showing that more than 28 million surgeries will be postponed or cancelled worldwide during the 12 weeks of peak disruption. There is a basic ethical responsibility to provide surgical care as a fundamental human right, in keeping with the principles espoused in the Universal Declaration of Human Rights. Additionally, improved access to high-quality surgical care is an essential component of universal health coverage and will contribute to good health and wellbeing, leading to improved human capital—all of which are vital for poverty reduction and economic growth on the continent. Human capital—the knowledge, skills, and health that people accumulate over their lifespan—is a primary driver of economic development. Investing in people by developing their skills, knowledge, and health allows them to be more productive, adaptable, and innovative, enabling meaningful participation in social, political, and economic life. The benefits of better health as human capital are visible at the individual, societal, and national levels. Healthy children thrive physically and mentally, which enables them to acquire knowledge and skills needed for the labour market. People with greater human capital earn higher wages and further invest in the education and health of family members and their community. This relation is especially visible in women's health, where poor maternal health can lead to long-term health consequences in women and children, negatively affecting the wellbeing and economic productivity of future generations.6, 7 Ultimately, educated, skilled, and healthier individuals are better placed to productively contribute to national socioeconomic development, while maximising available human capital. In 2015, an estimated 47% of all productivity losses in the WHO African region—approximately Int$1·4 trillion—were due to non-communicable diseases and injuries, which often require surgical systems for proper diagnosis, treatment, and management. In the past, substantial investments targeting infectious diseases and nutrition have led to improvements in health outcomes in sub-Saharan Africa. However, in view of changing disease epidemiology, it is likely that returns on these investments will only be partly realised unless substantial resources are invested in robust surgical systems to address the increasing burden of surgical conditions, which disproportionately affect the working-age population and children.3, 10 The demographic dividend in Africa will only be harnessed by reducing the dependency ratio and increasing the capacity of the working population to perform efficiently and effectively. Studies suggest that investment in surgical care will contribute substantially to human capital in sub-Saharan Africa.2, 11, 12 Caesarean delivery is the most widely performed surgical operation globally and is a critical intervention to reduce maternal mortality. However, in sub-Saharan Africa, maternal mortality after caesarean delivery is estimated to be as high as 543 per 100 000 operations—50 times higher than in high-income countries. Other conditions that require surgical care and severely affect human capital in sub-Saharan Africa are road traffic injuries. In 2016, the rate of these injuries in the WHO African region, at 26·6 road traffic deaths per 100 000 population, was the highest in the world—up from 26·1 per 100 000 population in 2013. Addressing trauma resulting from the rise in road traffic injuries and other sources of injuries, as well as mortality and morbidity from surgical conditions such as obstructed labour during pregnancy, will require investments in surgical systems. The 2015 Lancet Commission on global surgery estimated that up to $12·3 trillion in low-and-middle-income countries, or 2% of gross domestic product growth in middle-income countries, could be lost by 2030 without improved surgical systems. Improving surgical care should be considered an urgent matter, as conditions amenable to surgical care account for more annual deaths than HIV/AIDS, malaria, and tuberculosis combined.1, 2 The delivery of surgical care can be complex, requiring all components of the health system and the governance and organisation of diverse actors within that system. Nonetheless, programmes such as Narayana Hrudayalaya in India show that complex cardiovascular surgical interventions can be safely delivered in resource-limited settings at affordable costs. Using a combination of innovative processes and technologies, with a focus on efficiency and leveraging economies of scale, Narayana Hrudayalaya has been able to provide access to cardiac and other surgical care at low cost to thousands of Indians. Similar models could be adapted and scaled up in Africa to deliver a wide range of essential and emergency surgical care. Progress is already underway in several African countries. For example, six African countries have adopted national surgical, obstetric, and anaesthesia plans as roadmaps to systematically scale up surgical systems as a component of their national health strategic plans. The Southern African Development Community passed a regional resolution in 2018 specifically to improve surgical care. Several innovative affordable efforts to improve access to quality surgical care regionally, such as the East, Central and Southern Africa (ECSA) Collegiate training of surgeons, obstetricians, and anaesthesiologists, are showing early success. Such efforts should be supported politically and financially by African leaders. In 2015, the World Bank launched its Human Capital Project, which includes a human capital index that primarily aims to incentivise and support countries to invest in people for economic development and poverty reduction. In view of the high burden of surgical conditions in sub-Saharan Africa, investment in health systems capacity to deliver surgical care must be included in all efforts to increase human capital necessary for technological innovation and long-term economic growth in this region. Africa's most valuable resource is its people. Increased investment in the health of Africans will lead to economic growth in Africa. Millions of Africans who do not have access to surgical care, especially women and young adults, are prevented from achieving their maximum human capital, which is needed to compete in an increasingly technological and digital world. Therefore, African leaders have an ethical, social, and economic responsibility to invest in surgical care to increase the individual, societal, and national human capital needed to reap its demographic dividend.
  10 in total

1.  Global burden of surgical disease: an estimation from the provider perspective.

Authors:  Mark G Shrime; Stephen W Bickler; Blake C Alkire; Charlie Mock
Journal:  Lancet Glob Health       Date:  2015-04-27       Impact factor: 26.763

2.  The Brain Drain Myth: Retention of Specialist Surgical Graduates in East, Central and Southern Africa, 1974-2013.

Authors:  Avril Hutch; Abebe Bekele; Eric O'Flynn; Andrew Ndonga; Sean Tierney; Jane Fualal; Christopher Samkange; Krikor Erzingatsian
Journal:  World J Surg       Date:  2017-12       Impact factor: 3.352

Review 3.  Global economic consequences of selected surgical diseases: a modelling study.

Authors:  Blake C Alkire; Mark G Shrime; Anna J Dare; Jeffrey R Vincent; John G Meara
Journal:  Lancet Glob Health       Date:  2015-04-27       Impact factor: 26.763

4.  Catastrophic expenditure to pay for surgery worldwide: a modelling study.

Authors:  Mark G Shrime; Anna J Dare; Blake C Alkire; Kathleen O'Neill; John G Meara
Journal:  Lancet Glob Health       Date:  2015-04-27       Impact factor: 26.763

5.  Maternal and neonatal outcomes after caesarean delivery in the African Surgical Outcomes Study: a 7-day prospective observational cohort study.

Authors:  David Bishop; Robert A Dyer; Salome Maswime; Reitze N Rodseth; Dominique van Dyk; Hyla-Louise Kluyts; Janat T Tumukunde; Farai D Madzimbamuto; Abdulaziz M Elkhogia; Andrew K N Ndonga; Zipporah W W Ngumi; Akinyinka O Omigbodun; Simbo D Amanor-Boadu; Eugene Zoumenou; Apollo Basenero; Dolly M Munlemvo; Coulibaly Youssouf; Gabriel Ndayisaba; Akwasi Antwi-Kusi; Veekash Gobin; Patrice Forget; Bernard Mbwele; Henry Ndasi; Sylvia R Rakotoarison; Ahmadou L Samateh; Ryad Mehyaoui; Ushmaben Patel-Mujajati; Chaibou M Sani; Tonya M Esterhuizen; Thandinkosi E Madiba; Rupert M Pearse; Bruce M Biccard
Journal:  Lancet Glob Health       Date:  2019-04       Impact factor: 26.763

Review 6.  Global epidemiology of use of and disparities in caesarean sections.

Authors:  Ties Boerma; Carine Ronsmans; Dessalegn Y Melesse; Aluisio J D Barros; Fernando C Barros; Liang Juan; Ann-Beth Moller; Lale Say; Ahmad Reza Hosseinpoor; Mu Yi; Dácio de Lyra Rabello Neto; Marleen Temmerman
Journal:  Lancet       Date:  2018-10-13       Impact factor: 79.321

Review 7.  Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development.

Authors:  John G Meara; Andrew J M Leather; Lars Hagander; Blake C Alkire; Nivaldo Alonso; Emmanuel A Ameh; Stephen W Bickler; Lesong Conteh; Anna J Dare; Justine Davies; Eunice Dérivois Mérisier; Shenaaz El-Halabi; Paul E Farmer; Atul Gawande; Rowan Gillies; Sarah L M Greenberg; Caris E Grimes; Russell L Gruen; Edna Adan Ismail; Thaim Buya Kamara; Chris Lavy; Ganbold Lundeg; Nyengo C Mkandawire; Nakul P Raykar; Johanna N Riesel; Edgar Rodas; John Rose; Nobhojit Roy; Mark G Shrime; Richard Sullivan; Stéphane Verguet; David Watters; Thomas G Weiser; Iain H Wilson; Gavin Yamey; Winnie Yip
Journal:  Lancet       Date:  2015-04-26       Impact factor: 79.321

Review 8.  Maternal and child undernutrition: consequences for adult health and human capital.

Authors:  Cesar G Victora; Linda Adair; Caroline Fall; Pedro C Hallal; Reynaldo Martorell; Linda Richter; Harshpal Singh Sachdev
Journal:  Lancet       Date:  2008-01-26       Impact factor: 79.321

Review 9.  Economic Benefits of Investing in Women's Health: A Systematic Review.

Authors:  Kristine Husøy Onarheim; Johanne Helene Iversen; David E Bloom
Journal:  PLoS One       Date:  2016-03-30       Impact factor: 3.240

10.  Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans.

Authors: 
Journal:  Br J Surg       Date:  2020-06-13       Impact factor: 6.939

  10 in total
  2 in total

Review 1.  A Narrative Review of Kenya's Surgical Capacity Using the Lancet Commission on Global Surgery's Indicator Framework.

Authors:  Hugh Shirley; Richard Wamai
Journal:  Glob Health Sci Pract       Date:  2022-02-28

2.  The collateral damage of the COVID-19 pandemic on surgical health care in sub-Saharan Africa.

Authors:  Kathryn Chu; Ché L Reddy; Emmanuel Makasa
Journal:  J Glob Health       Date:  2020-12       Impact factor: 4.413

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.